Real-time reverse-transcription (RT)-PCR demonstrated that rhTGF-β1 induced TGF-β target gene PAI-1 expression (Figure 1C), indicating that TGF-β signaling is intact in these AML cells. The gene discussed is TGFB1; the disease is acute myeloid leukemia.